Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease ; volume:15 ; number:1 ; day:17 ; month:9 ; year:2016 ; pages:1-10 ; date:12.2016
Lipids in health and disease ; 15, Heft 1 (17.9.2016), 1-10, 12.2016
- Urheber
-
Paglialunga, Sabina
- Beteiligte Personen und Organisationen
-
Dehn, Clayton A.
SpringerLink (Online service)
- DOI
-
10.1186/s12944-016-0321-5
- URN
-
urn:nbn:de:1111-201610187391
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Paglialunga, Sabina
- Dehn, Clayton A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease
Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease
Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease
Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease